***Media Advisory***
WHAT: BioConference Live has selected Biodesix to present at the 5th annual Life Sciences conference, taking place online on October 26-27. Biodesix, based in Broomfield, CO, is a fully integrated molecular diagnostic company developing products for personalized medicine that improve clinical decision making. Paul Beresford, Biodesix Vice President, will discuss an alternative strategy for rapid companion diagnostic development, validation, and commercialization.
WHEN: October 26-27, 2011, 12:00 pm – 1:00 pm, Eastern Standard Time
WHERE: Online (www.bioconferencelive.com)
WHO: Paul Beresford, Pd.D., Vice President, Strategic Marketing and Business Development, Biodesix
For Customer Support, call: (866) 432-5930
Topics: BioConference Live, Biomarker Discovery, blood-based cancer test, cancer diagnostics, Cancer Research, diagnostic development, Drug Discovery, genetics, personalized medicine, Press Releases, Neuroscience, oncology
Biodesix, Inc. announces that Paul Beresford, Ph.D., Vice President, Business Development and Strategic Marketing will present at the 2011 Biotech ...
Learn more
BOULDER, Colo.—(BUSINESS WIRE)— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, ...
Learn more
WHAT: The Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) Selection Committee has chosen Biodesix to present to more than ...
Learn more
